Prednisone Course for Acute Gout Attack
For acute gout attacks, oral prednisone should be administered at 0.5 mg/kg per day for 5-10 days at full dose then stopped, or alternatively for 2-5 days at full dose followed by a 7-10 day taper. 1, 2
Treatment Algorithm for Acute Gout
First-Line Corticosteroid Options:
Oral Prednisone:
Injectable Options:
When to Choose Prednisone Over Other Options:
First-line in patients with:
- Renal disease
- Heart failure
- Cirrhosis
- Contraindications to NSAIDs or colchicine 2
Avoid in patients with:
- Uncontrolled diabetes
- Uncontrolled hypertension (consider NSAIDs or colchicine instead) 2
Combination Therapy for Severe Attacks
- For severe or polyarticular gout attacks, consider combination therapy:
Clinical Evidence and Considerations
- Randomized trials have demonstrated that oral prednisone (35 mg daily for 5 days) is equivalent to naproxen for pain reduction in acute gout 3
- Prednisone is particularly valuable when NSAIDs are contraindicated 4
- A 2024 trial (COPAGO) is comparing prednisolone 30 mg for 5 days with low-dose colchicine for acute gout, but results are not yet available 5
Monitoring and Safety
- Monitor for potential adverse effects with corticosteroid use:
- Elevated blood glucose (especially in diabetic patients)
- Blood pressure changes
- Mood disorders/dysphoria
- Immune suppression 2
- Short-term use (5-10 days) generally has minimal side effects when used for acute gout 4
Important Caveats
- Do not interrupt urate-lowering therapy during an acute attack 2
- Treatment should be initiated as soon as possible, ideally within 24 hours of symptom onset 2
- For long-term management, prophylaxis should be considered when initiating urate-lowering therapy 1, 2
- While evidence supports both fixed-duration and tapered approaches to prednisone therapy, there is no definitive evidence showing superiority of one approach over the other 1, 6
Prednisone represents an effective, evidence-based treatment option for acute gout attacks, particularly in patients with contraindications to NSAIDs or colchicine, with comparable efficacy and a favorable short-term safety profile.